SynthesisBMC gastroenterology2025
Infliximab for patients with moderate to severely active ulcerative colitis: an updated meta-analysis of randomized controlled trials.
Min Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it